Published in J Cell Physiol on July 01, 2002
What is hidden in the pannexin treasure trove: the sneak peek and the guesswork. J Cell Mol Med (2006) 0.98
Tumor necrosis factor alpha and epidermal growth factor act additively to inhibit matrix gene expression by chondrocyte. Arthritis Res Ther (2004) 0.92
Epidermal growth factor increases prostaglandin E2 production via ERK1/2 MAPK and NF-kappaB pathway in fibroblast like synoviocytes from patients with rheumatoid arthritis. Rheumatol Int (2009) 0.88
Epidermal growth factor activates Na(+/)H(+) exchanger in podocytes through a mechanism that involves Janus kinase and calmodulin. Biochim Biophys Acta (2009) 0.84
Resveratrol and N-acetylcysteine influence redox balance in equine articular chondrocytes under acidic and very low oxygen conditions. Free Radic Biol Med (2015) 0.77
Regulation of cancer cell migration and bone metastasis by RANKL. Nature (2006) 5.27
Deletion of the P2X7 nucleotide receptor reveals its regulatory roles in bone formation and resorption. Mol Endocrinol (2003) 1.93
Identification and management of latent tuberculosis infection. Am Fam Physician (2009) 1.57
Forced mobilization accelerates pathogenesis: characterization of a preclinical surgical model of osteoarthritis. Arthritis Res Ther (2007) 1.43
Inflammatory cytokines induce production of CHI3L1 by articular chondrocytes. J Biol Chem (2005) 1.42
P2X7 receptors on osteoblasts couple to production of lysophosphatidic acid: a signaling axis promoting osteogenesis. J Cell Biol (2008) 1.34
The induction of CCN2 by TGFbeta1 involves Ets-1. Arthritis Res Ther (2006) 1.33
Mathematical model predicts a critical role for osteoclast autocrine regulation in the control of bone remodeling. Bone (2003) 1.29
Convergent signaling by acidosis and receptor activator of NF-kappaB ligand (RANKL) on the calcium/calcineurin/NFAT pathway in osteoclasts. Proc Natl Acad Sci U S A (2005) 1.28
P2Y6 nucleotide receptors activate NF-kappaB and increase survival of osteoclasts. J Biol Chem (2005) 1.23
TNFalpha suppresses link protein and type II collagen expression in chondrocytes: Role of MEK1/2 and NF-kappaB signaling pathways. J Cell Physiol (2003) 1.22
P2X7 nucleotide receptors mediate blebbing in osteoblasts through a pathway involving lysophosphatidic acid. J Biol Chem (2006) 1.21
Expression, signaling, and function of P2X7 receptors in bone. Purinergic Signal (2009) 1.13
Extracellular acidification enhances osteoclast survival through an NFAT-independent, protein kinase C-dependent pathway. Bone (2007) 1.09
Functional characterization of oculodentodigital dysplasia-associated Cx43 mutants. Cell Commun Adhes (2006) 1.07
Transforming growth factor alpha suppression of articular chondrocyte phenotype and Sox9 expression in a rat model of osteoarthritis. Arthritis Rheum (2007) 1.04
Up-regulation of endogenous RGS2 mediates cross-desensitization between Gs and Gq signaling in osteoblasts. J Biol Chem (2006) 1.04
ODDD-linked Cx43 mutants reduce endogenous Cx43 expression and function in osteoblasts and inhibit late stage differentiation. J Bone Miner Res (2008) 1.03
Extracellular nucleotides act through P2X7 receptors to activate NF-kappaB in osteoclasts. J Bone Miner Res (2004) 1.01
Activation of P2X7 receptors causes isoform-specific translocation of protein kinase C in osteoclasts. J Cell Sci (2008) 0.99
RANK ligand-induced elevation of cytosolic Ca2+ accelerates nuclear translocation of nuclear factor kappa B in osteoclasts. J Biol Chem (2002) 0.97
Egr-1 inhibits the expression of extracellular matrix genes in chondrocytes by TNFalpha-induced MEK/ERK signalling. Arthritis Res Ther (2009) 0.96
Effects of isoform-selective phosphatidylinositol 3-kinase inhibitors on osteoclasts: actions on cytoskeletal organization, survival, and resorption. J Biol Chem (2013) 0.96
EP1 receptor-mediated migration of the first trimester human extravillous trophoblast: the role of intracellular calcium and calpain. J Clin Endocrinol Metab (2005) 0.95
Endothelin-1 promotes migration and induces elevation of [Ca2+]i and phosphorylation of MAP kinase of a human extravillous trophoblast cell line. Mol Cell Endocrinol (2003) 0.94
Tumor necrosis factor alpha and epidermal growth factor act additively to inhibit matrix gene expression by chondrocyte. Arthritis Res Ther (2004) 0.92
Proteomic analysis of the LPS-induced stress response in rat chondrocytes reveals induction of innate immune response components in articular cartilage. Matrix Biol (2007) 0.92
P2 receptor expression, signaling and function in osteoclasts. Front Biosci (Schol Ed) (2011) 0.91
LF15-0195 generates tolerogenic dendritic cells by suppression of NF-kappaB signaling through inhibition of IKK activity. J Leukoc Biol (2003) 0.91
Loss of equilibrative nucleoside transporter 1 in mice leads to progressive ectopic mineralization of spinal tissues resembling diffuse idiopathic skeletal hyperostosis in humans. J Bone Miner Res (2013) 0.90
P2Y nucleotide receptor signaling through MAPK/ERK is regulated by extracellular matrix: involvement of beta3 integrins. J Cell Physiol (2007) 0.90
Lysophosphatidic acid signals through multiple receptors in osteoclasts to elevate cytosolic calcium concentration, evoke retraction, and promote cell survival. J Biol Chem (2010) 0.88
P2X₇-mediated calcium influx triggers a sustained, PI3K-dependent increase in metabolic acid production by osteoblast-like cells. Am J Physiol Endocrinol Metab (2011) 0.88
Ascorbate uptake in pig coronary artery endothelial cells. Mol Cell Biochem (2005) 0.87
Osteopontin signals through calcium and nuclear factor of activated T cells (NFAT) in osteoclasts: a novel RGD-dependent pathway promoting cell survival. J Biol Chem (2011) 0.87
Loss of P2X7 nucleotide receptor function leads to abnormal fat distribution in mice. Purinergic Signal (2013) 0.86
P2 receptor networks regulate signaling duration over a wide dynamic range of ATP concentrations. J Cell Sci (2013) 0.85
Regulation of Sox9 activity by crosstalk with nuclear factor-kappaB and retinoic acid receptors. Arthritis Res Ther (2008) 0.85
Noncatalytic domain of uPA stimulates human extravillous trophoblast migration by using phospholipase C, phosphatidylinositol 3-kinase and mitogen-activated protein kinase. Exp Cell Res (2003) 0.84
One- and three-dimensional growth of hydroxyapatite nanowires during sol-gel-hydrothermal synthesis. ACS Appl Mater Interfaces (2012) 0.83
Coenzyme Q(1) depletes NAD(P)H and impairs recycling of ascorbate in astrocytes. Brain Res (2006) 0.83
Effects of Vitaxin, a novel therapeutic in trial for metastatic bone tumors, on osteoclast functions in vitro. J Cell Biochem (2007) 0.83
Acute vibration induces transient expression of anabolic genes in the murine intervertebral disc. Arthritis Rheum (2013) 0.83
Control of surface topography in biomimetic calcium phosphate coatings. Langmuir (2012) 0.82
Lysophosphatidic acid: a potential mediator of osteoblast-osteoclast signaling in bone. Biochim Biophys Acta (2012) 0.82
Activation of transcription factors by extracellular nucleotides in immune and related cell types. Purinergic Signal (2007) 0.82
The differential regulation of osteoblast and osteoclast activity by surface topography of hydroxyapatite coatings. Biomaterials (2013) 0.81
Bioactive glass/polymer composite materials with mechanical properties matching those of cortical bone. J Biomed Mater Res A (2006) 0.79
Dehydroascorbic acid uptake by coronary artery smooth muscle: effect of intracellular acidification. Biochem J (2002) 0.79
PKC inhibition increases gap junction intercellular communication and cell adhesion in human neuroblastoma. Cell Tissue Res (2010) 0.78
Cyclic AMP regulates extracellular matrix gene expression and metabolism in cultured primary rat chondrocytes. Matrix Biol (2009) 0.78
Real-time measurement of cytosolic free calcium concentration in Jurkat cells during ELF magnetic field exposure and evaluation of the role of cell cycle. Bioelectromagnetics (2006) 0.77
N-butyryl glucosamine increases matrix gene expression by chondrocytes. J Pharmacol Exp Ther (2004) 0.77
Pharmacokinetic considerations in determining the terminal elimination half-lives of bisphosphonates. Clin Drug Investig (2005) 0.77
Monocytes from patients with osteoarthritis display increased osteoclastogenesis and bone resorption: the In Vitro Osteoclast Differentiation in Arthritis study. Arthritis Rheum (2013) 0.77
Tissue engineering scaffolds for the regeneration of craniofacial bone. J Can Dent Assoc (2009) 0.76
Activity restriction increases deoxypyridinoline excretion in hospitalized high-risk pregnant women. Biol Res Nurs (2012) 0.76
Differential effects of glucose on dehydroascorbic acid transport and intracellular ascorbate accumulation in astrocytes and skeletal myocytes. Brain Res (2003) 0.76
Latent tuberculosis infection: the physician's role in tuberculosis control. Am Fam Physician (2009) 0.75
Receptor-independent effects of 2'(3')-O-(4-benzoylbenzoyl)ATP triethylammonium salt on cytosolic pH. Purinergic Signal (2013) 0.75
Optical waveguides formed by silver ion exchange in Schott SG11 glass for waveguide evanescent field fluorescence microscopy: evanescent images of HEK293 cells. J Biomed Opt (2010) 0.75
Synthesis of bioactive and machinable miserite glass-ceramics for dental implant applications. Dent Mater (2013) 0.75
A Comparison of the Mechanical Measures Used for Assessing Orthodontic Mini-Implant Stability. Implant Dent (2016) 0.75
Controlled deposition of highly oriented type I collagen mimicking in vivo collagen structures. Langmuir (2010) 0.75
Subcellular elevation of cytosolic free calcium is required for osteoclast migration. J Bone Miner Res (2014) 0.75
Visualization of the solubilization process of the plasma membrane of a living cell by waveguide evanescent field fluorescence microscopy. J Biomed Opt (2012) 0.75